Search Results 1211-1220 of 18529 for hepatitis

1. Study of Sparsentan in Patients with Primary Focal Segmental Glomerulosclerosis - Mayo Clinic

   ... hepatitis B virus (HBV) infection (acute HBV is defined as a positive hepatitis B surface antigen [HBsAg], hepatitis B “e” antigen [HBeAg], HBV DNA in blood ...

2. Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas - Mayo Clinic

   Specific exclusions: Evidence of hepatitis B, C, or HIV; History of cancer including melanoma (with the exception of localized skin cancers); Investigational ...

3. Non-Invasive Method of Diagnosing Rejection for Liver Transplant Patients - Mayo Clinic

   Autoimmune etiology of the original liver disease (autoimmune hepatitis, primary biliary cirrhosis or primary sclerosing cholangitis); Recipients of donation ...

4. Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   ... hepatitis B (hepatitis B surface antigen [HBsAg] and/or total hepatitis B core antibody [anti-HBc]) or HCV antibody. Unless required by local regulations ...

5. "Liver in a box" offers potential for providing liver transplant to more patients - Mayo Clinic

   Mathur. "If doctors are concerned that a patient may need a liver transplant to treat advanced liver disease such as hepatitis, cirrhosis, liver cancers and ...

6. A Study of Lenalidomide Combined with a Standard Chemotherapy for Treating Patients with Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma - Mayo Clinic

   ... hepatitis B virus (HBV) or hepatitis C virus (HCV). If seropositive because of hepatitis B virus vaccine, then still eligible. Major surgery within 2 weeks of ...

7. Many ophthalmic irAEs can be treated without discontinuation of life-prolonging immunotherapy - Mayo Clinic

   Patients with ophthalmic side effects associated with combination therapy had a higher frequency of hepatitis as a concurrent systemic adverse effect.

8. Mayo Clinic Cardiovascular Disease Biobank

   Patients with hepatitis B, hepatitis C, or human immunodeficiency virus (HIV). Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

9. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Infection with HIV, hepatitis B, or hepatitis C. Presence of Child-Pugh Class C hepatic impairment. Active TB or history of latent TB that has not been ...

10. Dr. Mody 02-22-2021 - Mayo Clinic News Network

    which can be caused by chronic hepatitis and, and other things, you know, frequently known as ... I will say, when I say cirrhosis and chronic liver disease, you ...